Rachel Yehuda, PhD

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Psychiatry, James J. Peters Veterans Affairs Medical Center, Bronx, New York

  • 12Articles
  • 34.5KReads
  • 1999–2026Active
  • 57Collaborators
  • 64Citations

About

Rachel Yehuda, PhD, is affiliated with the Department of Psychiatry at Icahn School of Medicine at Mount Sinai and the James J. Peters Veterans Affairs Medical Center. Her publications, spanning from 1999 to 2026, focus on posttraumatic stress disorder (PTSD), including its biological underpinnings, treatment approaches such as cognitive-behavioral therapy and pharmacotherapy, and associated conditions like metabolic disorders and aggression. Yehuda has contributed extensively to research on PTSD pathophysiology, clinical interventions, and risk and resilience factors. Frequent collaborators include Adriana Feder, Arieh Y. Shalev, and Robert H. Pietrzak.

Publications

PCC
Intrusive PTSD Symptoms and Elevated CRP in World Trade Center Responders
Original Research

Intrusive PTSD Symptoms and Elevated CRP in World Trade Center Responders

September 1, 2026

Intrusive PTSD symptoms may contribute to systemic inflammation in WTC responders, thus targeting both PTSD symptoms and obesity/dyslipidemia may help mitigate risk for elevated systemic inflammation.
, , , et al
JCP
Ketamine Infusions and Written Exposure Therapy for Chronic PTSD
Original Research

Ketamine Infusions and Written Exposure Therapy for Chronic PTSD

April 2, 2025

Preliminary findings suggest that the combined treatment may yield large and durable symptom reductions for patients with severe chronic PTSD
, , , et al
JCP
Original Research

Is Trauma a Causal Agent of Psychopathologic Symptoms in Posttraumatic Stress Disorder? Findings From Identical Twins Discordant for Combat Exposure

September 7, 2010

, , , et al
JCP
Original Research

A Randomized Controlled Trial of the Safety and Promise of Cognitive-Behavioral Therapy Using Imaginal Exposure in Patients With Posttraumatic Stress Disorder Resulting From Cardiovascular Illness

April 13, 2010

, , , et al
JCP
Article

Risk and Resilience in Posttraumatic Stress Disorder

December 15, 2004

JCP
Article

Consensus Statement Update on Posttraumatic Stress Disorder From the International Consensus Group on Depression and Anxiety

January 1, 2004

, , , et al
JCP
Original Research

Paroxetine in the Treatment of Chronic Posttraumatic Stress Disorder: Results of a Placebo-Controlled, Flexible-Dosage Trial

November 1, 2001

, , , et al
JCP
Article

Biology of HPA Axis in PTSD

January 3, 2001

Read an article about the biology of HPA Axis in posttraumatic stress disorder (PTSD) and reasoning for a reduction in cortisol levels in patients.
JCP
Article

Introduction: Understanding Posttraumatic Stress Disorder (PTSD):An Overview

January 3, 2001

JCP
Article

Biology of Posttraumatic Stress Disorder

April 30, 2000

Read an article examining the biological alterations in posttraumatic stress disorder and the development progression of the neurobiology of this disorder.
PCC
Article

Biology of Posttraumatic Stress Disorder

April 30, 2000

JCP
Article

Managing Anger and Aggression in Patients With Posttraumatic Stress Disorder

June 1, 1999

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe